NAD OKs 3 Of 15 Studies For Ameal BP Claims Substantiation

This article was originally published in The Tan Sheet

11 Aug 2008
News

Jessica Lake j.lake@elsevier.com

Executive Summary

Calpis USA should link claims for its ameal bp dietary supplement to only three of the 15 clinical trials it has cited as substantiation, the National Advertising Division says

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS101979

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS101979

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

NAD OKs 3 Of 15 Studies For Ameal BP Claims Substantiation

News

Executive Summary

Related Content

No Concealing Cosmeceutical Claims From NAD, FTC

No Concealing Cosmeceutical Claims From NAD, FTC

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert